Efficacy of baricitinib 4 mg in patients with moderate‐to‐severe atopic dermatitis previously treated with systemic therapy

• Main Authors: Antonio Costanzo (Author), Akio Tanaka (Author), Tiago Torres (Author), Bibiana Pérez‐García (Author), Angelina Sontag (Author), Yun‐Fei Chen (Author), Fan Emily Yang (Author), Jill Kolodsick (Author), Hitoe Torisu‐Itakura (Author), Najwa Somani (Author)
• Format: Book
• Published: Wiley, 2023-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background The Janus kinase (JAK)1/JAK2 inhibitor baricitinib in combination with topical corticosteroids (TCS) improved moderate‐to‐severe atopic dermatitis (AD) in the phase 3 BREEZE‐AD7 trial. Patients with previous systemic therapy may have more severe, treatment‐resistant disease. Obje...